<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000662959"><TermName>CDK inhibitor SCH 727965</TermName><TermPronunciation>(… in-HIH-bih-ter …)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of advanced melanoma (a type of skin cancer) and other types of cancer. It blocks cell division and may cause cancer cells to die. It is a type of cyclin-dependent kinase inhibitor. Also called dinaciclib.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000726182" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;CDK inhibitor SCH 727965&quot;" language="en" id="_3"/><MediaLink ref="CDR0000726183" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inhibidor SCH 727965 de CDC&quot;" language="es" id="_4"/><SpanishTermName>inhibidor SCH 727965 de CDC</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del melanoma (un tipo de cáncer de piel) en estadio avanzado, así como otros tipos de cáncer. Impide la multiplicación celular y podría destruir las células cancerosas. Es un tipo de inhibidor de la cinasa dependiente de ciclinas.  También se llama dinaciclib.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-05-26</DateFirstPublished></GlossaryTerm>
